Comparison of the Risk of Diabetic Retinopathy Between Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus in Japan: A Retrospective Analysis of Real-World Data
In this study, the risk of DR diagnosis was lower with SGLT2i compared with DPP-4i in patients with T2DM without microvascular and macrovascular diseases in Japan. Findings suggest that early SGLT2i treatment may be beneficial in preventing DR development in early-stage T2DM. Graphical abstract available for this article.
Authors
- Fumiko Kiyonaga
- Yoshinori Kosakai
- Tomoaki Tatsumi (ORCID: https://orcid.org/0000-0001-8271-9403)
- Masaya Koshizaka (ORCID: https://orcid.org/0000-0001-7374-9993)
- Yoko Yoshinaga (ORCID: https://orcid.org/0000-0003-4664-0671)
- Mami Shintani‐Tachi
Institutions
- Astellas Pharma (Japan) (JP)
- Chiba University (JP)
- Chiba University Hospital (JP)
- Teikyo University Chiba Medical Center (JP)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1007/s13300-024-01649-9
- Citations
- 8
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.86
Funders
- Astellas Pharma